Assay Depot Rebrands as Scientist

We are excited to announce that Assay Depot has been rebranded as Scientist.com. Our domain name has changed to www.scientist.com but you can still...
Kevin Lustig
CEO
Scientist.com
公開日
June 4, 2016

We are excited to announce that Assay Depot has been rebranded as Scientist.com . Our domain name has changed to www.scientist.com but you can still access the marketplace by logging in with your same username and password. You can continue to use the marketplace to get quotes and purchase research services exactly as before.

We believe that the Scientist.com marketplace will transform the trillion dollar pharmaceutical industry in much the same way the Amazon, AirBNB and Uber marketplaces have transformed the retail, hotel and transportation industries. Through commoditization and modularization of drug research services, Scientist dramatically shortens the R&D cycle and substantially reduces costs.

More importantly, the Scientist.com marketplace also enables a virtuous cycle of “compound innovation,” in which the barriers to innovation are greatly lowered. In finance, compound interest can greatly increase your monetary return. In research, compound innovation can greatly increase your scientific return. By taking advantage of compound innovation, we believe that the pharma industry could produce five times as many new medicines each year - without increasing its research budget.

We have already established long-term partnerships with 10 of the world’s largest research companies. Our goal over the next few years is to work with our partners to demonstrate that we can achieve compound innovation by Outsourcing Everything But the Genius™.

Abstract molecular cluster with three connected blue-green spheres on a white background.

次のステップへ進む

1
2
3

Explore Suppliers

関連する専門知識を持つ信頼できるパートナーを探す

Review Capabilities

サービス、経験、実績を比較する

Start Your Project

つながり、協業を始める

執筆者
Kevin Lustig
CEO
Scientist.com

Kevin Lustig is a scientist-entrepreneur with 30 years of research experience in academia and pharma. He co-founded Scientist.com in 2007. In 2001, he co-founded Kalypsys, a small pharmaceutical company. He was Director of Lead Discovery at Tularik from 1997-2001. He carried out postdoctoral work at Harvard Medical School after receiving a PhD degree from Marc Kirschner’s laboratory at UC-San Francisco and an A.B. degree, magna cum laude, from Cornell University.

この記事をシェアする

続きを読む

続きを読む